The $43B Big Pharma Story is Starting Over-With a New Player
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Shares Stats
| Shares Outstanding | 146,700,000 |
| Shares Float | 146,440,000 |
| Shares Short | 6,140,000 |
| Insider Holdings | 15% |
| Institution Holdings | 95.50% |
About Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS; and TOFIDENCE, a tocilizumab biosimilar referencing ACTEMRA. It offers RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, and biosimilars. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; and Sage Therapeutics, Inc., as well as collaborations with Fujirebio to identify and develop biomarkers for tau pathology in the brain and Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
General
| Name | Biogen Inc |
| Ticker | BIIB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 7,605 |
Highlights
| Analyst Target | 180.50 |
| Market Cap | 26,801,000,000 |
| PE Ratio | 16.66 |
| PEG Ratio | 5.17 |
| EBITDA | 3,409,299,968 |
Financials
| Curr Year EPS Estimate | 15.06 |
| Next Quarter EPS Estimate | 3.38 |
| Profit Margin | 16.60% |
| Operating Margin | 25.17 |
| Return on Assets | 0.06 |
| Return on Equity | 0.09 |
| Revenue | 9.7B |
| Earnings Per Share | 10.97 |
| Revenue Per Share | 68.82 |
| Gross Profit | 7,706,800,128 |
| Quarterly Revenue Growth | 0.03 |
Valuation
| Trailing PE | 16.42 |
| Forward PE | 11.38 |
| Price/Sales (Trailing 12 Mt.) | 2.63 |
| Price/Book (Most Recent Quarter) | 1.43 |
Earnings
Coinbase Stock Rebounds As Bitcoin Reclaims $92,000 Level
Coinbase Global Inc.
Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data
Black Diamond posts strong Phase 2 lung cancer results with a 60% response rate and solid safety profile while preparing major trial updates and GBM expansion plans.
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Walmart Stock Just Hit A New All-Time High: What's Going On?
Walmart Inc (NYSE: WMT) shares are trading higher on Wednesday, reaching a new all-time high. Here's what you need to know.
American Eagle Outfitters Stock Smashes 52-Week High On Holiday Momentum
American Eagle Outfitters (AEO) stock hits 52-week high after reporting strong Q3 results and raised guidance for holiday season.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
Trump plans to weaken vehicle mileage rules that limit air pollution
WASHINGTON (AP) — is expected to announce a proposal Wednesday to weaken for the auto industry, loosening regulatory pressure on automakers to control pollution from gasoline-powered cars and trucks, according to several people familiar with the White House plans.
Trump 'Very Seriously' Considering Australian Retirement Savings System For US Working People: 'It's A Good Plan'
President Donald Trump has revealed that his administration is actively exploring the possibility of implementing a retirement savings system similar to Australia's in the United States.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
DOJ Greenlights Strikes on Drug Boats, Citing Fentanyl as Potential Chemical Weapon
The DOJ has classified Fentanyl as a potential chemical weapon. This classification has led to the authorization of strikes on drug-smuggling boats.
FDA Clears Arrowhead Pharma's First-Ever Home Injection For Rare Fat Disorder
Arrowhead Pharmaceuticals won FDA approval for Redemplo (plozasiran), an siRNA drug reducing high triglycerides in adults with rare FCS.
Retire Comfortably with These New Monthly Income ETFs? - Ad
Retirement should be freedom, not stress. Yet outdated advice and tiny returns leave many trapped. Kelly G. broke free with a revolutionary income strategy once reserved for the wealthy - hitting her "Freedom Number" faster than she dreamed. You might already have enough too.
Trump attacks ABC News correspondent Mary Bruce in angry response to three sharp questions
NEW YORK (AP) — President Donald Trump denounced ABC News' Mary Bruce as a “terrible reporter” Tuesday and threatened the network's license to broadcast after she asked him three sharp questions at the White House.
Scaramucci Says This One US Mistake Helped China Become a Manufacturing Superpower
Anthony Scaramucci recently highlighted what he considers a significant error by the US that enabled China to ascend as a manufacturing superpower.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Costco becomes biggest company yet to demand refund of Trump tariffs
WASHINGTON (AP) — Costco is joining other companies that aren't waiting to see President Donald Trump's most sweeping import taxes. They're going to court to demand refunds on the tariffs they've paid.
BRICS Outpaces G7, The Undeniable Economic Rebalancing
BRICS+ now has a larger share of world GDP than G7. BRICS+ GDP, measured in PPP, is $75.6 trillion vs. G7's $56.6 trillion.
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Here's How Americans Spent a Record $18 Billion Chasing Thanksgiving Week Deals
American consumers have demonstrated their purchasing power this Black Friday.
John Bolton Questions Trump's Latest 'Incoherent Strategy' To Achieve Ukraine-Russia Agreement, Calls It 'Typically Trumpian'
Bolton criticizes Trump's 28-point peace proposal for Russia-Ukraine conflict as incoherent and lacking strategy, claiming it benefits Moscow.
The Next Biggest Bull Run In Over 50 Years - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Salesforce Q3 Preview: Record Revenue Predicted, Can Shares Recover After 30% Drop In 2025?
Salesforce shares are down in 2025. The company's Q3 results and Q4 guidance could see shares volatile in the last month of the year.
Some friendly, some on-the-news questions at first briefing for new Pentagon press corps
The new journalism guard is officially in at the Pentagon. And the questions being asked of those running the world's most powerful military range from softballs to pointed queries to performances.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
Airbus Orders Emergency Recall Of 6,000 A320 Jets After JetBlue Incident, Triggering Global Flight Delays And Holiday Travel Chaos
Airbus SE (OTC: EADSF) ordered immediate repairs to A320-family aircraft on Friday, recalling 6,000 jets after a recent JetBlue incident.
Trump Withdraws Support For 'Wacky' Marjorie Taylor Greene In Sudden, Fiery Split: 'I Can't Take...'
President Donald Trump said he is withdrawing his endorsement of longtime ally Rep. Marjorie Taylor Greene — here's what happened.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Silver Breaks Out In A Short Squeeze, Rising Yields In Japan Hits Stocks and Bitcoin
Rising Yields In Japan
California revokes 17,000 driver's licenses. But the state disputes it is over immigration concerns
California plans to revoke 17,000 commercial driver’s licenses given to immigrants after the Trump administration raised concerns about people in the country illegally receiving licenses to drive a semitruck or a bus. But Gov. Gavin Newsom said that isn't the reason.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
A New Take On Bitcoin, Ethereum And IPO Investing? VistaShares' ETF Quartet Suggests So
VistaShares files four new ETFs combining Bitcoin, Ethereum and IPO themes with yield-focused strategies.
AT&T reached a $177M data breach settlement. What consumers should know about claiming their money
NEW YORK (AP) — AT&T has reached a combined $177 million settlement over two . And impacted consumers have a little over a month left to file a claim for their chunk of the money.
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Iran confirms seizure of oil tanker in the Strait of Hormuz
TEHRAN, Iran (AP) — Iran on Saturday confirmed as it traveled through the narrow Strait of Hormuz over violations including carrying an illegal consignment, state media reported.
Cathie Wood Bets Big On These Stocks As Bitcoin, Ethereum Crash —Dumps Instagram Rival
On Tuesday, Cathie Wood-led Ark Invest made significant trades, notably increasing its holdings in Bullish (NYSE:BLSH), Coinbase Glo
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
All 14 victims identified from fiery UPS cargo plane crash in Louisville
LOUISVILLE, Ky. (AP) — A grandfather and his young granddaughter. An electrician with two young children. A woman standing in line at a scrap metal business.
OpenAI CEO Sam Altman declares 'code red' to improve ChatGPT amid rising competition in AI chatbots
SAN FRANCISCO (AP) — OpenAI CEO Sam Altman has set off a “code red” alert to employees to improve its flagship product, ChatGPT, and delay other product developments, according to The Wall Street Journal.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
A lost generation of news consumers? Survey shows how teenagers dislike the news media
NEW YORK (AP) — Cat Murphy, a college student, has wanted to be a journalist since she was 11. Many of her friends don't understand why.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.